Table 1.
Demographic and clinical data for the studied groups and control
| A | B | Total | Control | P value | |
| (n = 31) | (n = 29) | (n = 60) | (n = 28) | ||
| Age (yr) | 11.1 ± 2.178 | 11.043 ± 2.882 | 11.17 ± 2.293 | 9.35 ± 3.24 | 0.445 |
| Duration of illness (yr) | 3.4 ± 1.984 | 3.123 ± 1.688 | 3.262 ± 1.832 | - | 0.563 |
| BMI (kg/m2) | 20.81 ± 4.29 | 20.28 ± 3.13 | 20.54 ± 3.73 | 21.21 ± 2.34 | 0.588 |
| Male/female | 23/8 (74.1%/25.8%) | 20/9 (68.9%/31.1%) | 43/17 (71.6%/28.3 %) | 17/13 (60.7%/46.4%) | 0.284 |
| Blood transfusion, n (%) | 16 (51.6) | 16 (55.1) | 32 (53.3) | - | 0.602 |
| Positive family history of HCV | 8 (25.8) | 1 (3.4) | 9 (15.0) | - | 0.051 |
| Jaundice, n (%) | 19 (61.2) | 13 (44.8) | 32 (53.3) | - | 0.098 |
| Fever, n (%) | 9 (29.0) | 9 (31.0) | 18 (30.0) | - | 0.611 |
| History of bleeding, n (%) | 17 (54.8) | 16 (55.1) | 33 (55.0) | - | 0.501 |
1
Significance total vs control. No significant difference between group A and B. Data are presented as the mean ± SD or number (%) as appropriate. BMI: Body mass index.